{"hands_on_practices": [{"introduction": "The cornerstone of evaluating suspected Heparin-Induced Thrombocytopenia (HIT) is a structured clinical assessment. This exercise guides you through the application of the 4Ts score, the most widely used clinical prediction rule for estimating the pretest probability of HIT. By systematically analyzing a patient's clinical data, you will practice quantifying risk, a foundational skill that determines the entire subsequent diagnostic and management cascade [@problem_id:4845902].", "problem": "A hospitalized $68$-year-old man is treated with unfractionated heparin for prevention of pulmonary embolism after major orthopedic surgery. His baseline platelet count before heparin was $250 \\times 10^{9}/\\mathrm{L}$. On hospital day $5$ after starting heparin (day $0$), his platelet count begins to fall, reaching a nadir of $100 \\times 10^{9}/\\mathrm{L}$ by day $7$, and stabilizes thereafter. On day $7$, he develops ipsilateral leg swelling and duplex ultrasonography confirms a new occlusive deep vein thrombosis (DVT). On day $6$, he had a fever of $38.5\\,^{\\circ}\\mathrm{C}$ and leukocytosis; blood cultures are pending and a possible sepsis syndrome is raised by the intensive care team, but no source is identified and no vasopressor support is required. There was no prior heparin exposure documented within the preceding $100$ days.\n\nUsing established, evidence-based clinical prediction rules for Heparin-Induced Thrombocytopenia (HIT), infer the appropriate assignments for the four domains that constitute the $4\\mathrm{Ts}$ clinical score—namely thrombocytopenia, timing of platelet count fall, thrombosis or other sequelae, and other causes for thrombocytopenia—and compute the total $4\\mathrm{Ts}$ score. Then, encode the resulting pretest probability category as follows: low pretest probability $\\mapsto 0$, intermediate pretest probability $\\mapsto 1$, high pretest probability $\\mapsto 2$.\n\nExpress your final answer as a row matrix containing, in order, the total $4\\mathrm{Ts}$ score and the encoded pretest probability value. No rounding is required, and no units should be included inside the matrix.", "solution": "The problem statement is a clinical vignette requiring the application of the $4\\mathrm{Ts}$ score, an established, evidence-based clinical prediction rule for Heparin-Induced Thrombocytopenia (HIT). The problem is scientifically grounded, well-posed, and objective. All necessary data for the calculation are provided. Therefore, the problem is valid.\n\nThe $4\\mathrm{Ts}$ score is calculated by assigning points across four domains: Thrombocytopenia, Timing, Thrombosis, and oTher causes. We will evaluate each domain based on the provided clinical information.\n\n1.  **Thrombocytopenia (the first 'T')**: This component is scored based on the magnitude of the platelet count fall and the platelet nadir.\n    *   The baseline platelet count is given as $P_{baseline} = 250 \\times 10^{9}/\\mathrm{L}$.\n    *   The nadir platelet count is given as $P_{nadir} = 100 \\times 10^{9}/\\mathrm{L}$.\n    *   The absolute platelet count fall is $P_{fall} = P_{baseline} - P_{nadir} = (250 - 100) \\times 10^{9}/\\mathrm{L} = 150 \\times 10^{9}/\\mathrm{L}$.\n    *   The percentage platelet count fall is calculated as:\n        $$ \\text{Percentage Fall} = \\frac{P_{fall}}{P_{baseline}} \\times 100\\% = \\frac{150 \\times 10^{9}/\\mathrm{L}}{250 \\times 10^{9}/\\mathrm{L}} \\times 100\\% = 0.6 \\times 100\\% = 60\\% $$\n    *   The scoring rules for this domain are:\n        *   $2$ points for a platelet count fall $ 50\\%$ OR a platelet nadir of $20-100 \\times 10^{9}/\\mathrm{L}$.\n        *   $1$ point for a platelet count fall of $30-50\\%$ OR a platelet nadir of $10-19 \\times 10^{9}/\\mathrm{L}$.\n        *   $0$ points for a platelet count fall $ 30\\%$ OR a platelet nadir $ 10 \\times 10^{9}/\\mathrm{L}$.\n    *   The patient's platelet fall is $60\\%$, which is greater than $50\\%$. The nadir is $100 \\times 10^{9}/\\mathrm{L}$, which falls within the $20-100 \\times 10^{9}/\\mathrm{L}$ range. Either condition is sufficient for the maximum score.\n    *   Therefore, the score for Thrombocytopenia is $2$ points.\n\n2.  **Timing of platelet count fall (the second 'T')**: This component assesses the temporal relationship between heparin exposure and the onset of thrombocytopenia.\n    *   The problem states that the platelet count begins to fall on day $5$ after starting heparin (with day $0$ being the start day).\n    *   The scoring rules for this domain are:\n        *   $2$ points for a clear onset of fall between days $5$ and $10$ of heparin exposure.\n        *   $1$ point for a fall consistent with days $5-10$ but not clear, or onset after day $10$.\n        *   $0$ points for a fall at or before day $4$ without recent heparin exposure.\n    *   The patient has no prior heparin exposure within the preceding $100$ days. The fall begins on day $5$, which is the classic time window for the development of heparin-dependent antibodies.\n    *   Therefore, the score for Timing is $2$ points.\n\n3.  **Thrombosis or other sequelae (the third 'T')**: This component accounts for new thrombotic events or other clinical sequelae associated with HIT.\n    *   The patient develops a \"new occlusive deep vein thrombosis (DVT)\" on day $7$, which is confirmed by duplex ultrasonography.\n    *   The scoring rules for this domain are:\n        *   $2$ points for new, confirmed thrombosis; skin necrosis; or an acute systemic reaction post-heparin bolus.\n        *   $1$ point for progressive/recurrent thrombosis; non-necrotizing skin lesions; or suspected but unproven thrombosis.\n        *   $0$ points for no thrombosis.\n    *   The patient has a new, proven thrombosis.\n    *   Therefore, the score for Thrombosis is $2$ points.\n\n4.  **oTher causes for thrombocytopenia (the fourth 'T')**: This component considers alternative explanations for the low platelet count.\n    *   The problem notes that the patient had major orthopedic surgery, which can cause a modest platelet drop. Furthermore, \"a possible sepsis syndrome is raised by the intensive care team\" due to fever ($38.5\\,^{\\circ}\\mathrm{C}$) and leukocytosis. Sepsis is a common cause of thrombocytopenia.\n    *   The scoring rules for this domain are:\n        *   $2$ points for no other cause being apparent.\n        *   $1$ point for a possible other cause.\n        *   $0$ points for a definite other cause.\n    *   While sepsis is considered, it is not confirmed (\"no source is identified\"), and the patient is hemodynamically stable (\"no vasopressor support is required\"). Major surgery is also a potential contributor. The explicit mention of a \"possible sepsis syndrome\" directly corresponds to the criteria for \"a possible other cause\".\n    *   Therefore, the score for oTher causes is $1$ point.\n\nTotal $4\\mathrm{Ts}$ Score:\nThe total score is the sum of the scores from the four domains:\n$$ S_{4\\mathrm{Ts}} = (\\text{Score}_{Thrombocytopenia}) + (\\text{Score}_{Timing}) + (\\text{Score}_{Thrombosis}) + (\\text{Score}_{oTher}) $$\n$$ S_{4\\mathrm{Ts}} = 2 + 2 + 2 + 1 = 7 $$\nA total score of $7$ points is obtained.\n\nPretest Probability Category:\nThe total score is used to stratify patients into pretest probability categories for HIT:\n*   Low probability: $0-3$ points\n*   Intermediate probability: $4-5$ points\n*   High probability: $6-8$ points\n\nA score of $7$ falls into the **high pretest probability** category.\n\nEncoding the Pretest Probability:\nThe problem specifies the following encoding scheme:\n*   Low pretest probability $\\mapsto 0$\n*   Intermediate pretest probability $\\mapsto 1$\n*   High pretest probability $\\mapsto 2$\n\nSince the patient is in the high pretest probability category, the encoded value is $2$.\n\nThe final answer is a row matrix containing the total $4\\mathrm{Ts}$ score and the encoded probability value. The two values are $7$ and $2$.", "answer": "$$ \\boxed{ \\begin{pmatrix} 7  2 \\end{pmatrix} } $$", "id": "4845902"}, {"introduction": "Once a pretest probability is established, laboratory testing is used to refine the diagnosis, but interpreting these results requires a quantitative approach. This practice problem demonstrates how to use the odds-based formulation of Bayes' theorem to sequentially update the likelihood of HIT after receiving results from both an immunoassay and a functional assay [@problem_id:4845848]. Mastering this skill is essential for navigating the common clinical dilemma of discordant test results and making evidence-based decisions.", "problem": "A patient with suspected Heparin-Induced Thrombocytopenia (HIT) has a pretest probability derived from the 4Ts clinical score of $0.15$. The diagnostic pathway consists of two sequential tests: first, an Enzyme-Linked Immunosorbent Assay (ELISA) for platelet factor $4$ (PF4)/heparin antibodies that returns positive, and second, a Serotonin Release Assay (SRA) that returns negative. The ELISA has a positive likelihood ratio $LR^{+} = 2$, and the SRA has a negative likelihood ratio $LR^{-} = 0.05$. Assume conditional independence of test results given disease status, and use the odds-based formulation of Bayes theorem grounded in the core definitions of probability, odds, and likelihood ratios. Starting from the given pretest probability, compute the post-test probability after the positive ELISA and then the post-test probability after the subsequent negative SRA, applying odds multiplication sequentially. Express each final probability as a fraction in simplest terms. Provide both probabilities in order (after ELISA, then after SRA). No rounding is required.", "solution": "The problem requires the sequential calculation of post-test probabilities for Heparin-Induced Thrombocytopenia (HIT) using the odds-based formulation of Bayes' theorem. The process begins with a given pre-test probability and updates it after two consecutive diagnostic tests.\n\nThe relationship between probability ($P$) and odds ($O$) is fundamental to this method. The odds of an event are defined as the ratio of the probability of the event occurring to the probability of it not occurring:\n$$O = \\frac{P}{1-P}$$\nConversely, probability can be calculated from odds using the formula:\n$$P = \\frac{O}{1+O}$$\nBayes' theorem, in its odds form, states that the post-test odds are the product of the pre-test odds and the likelihood ratio ($LR$) of the test result:\n$$O_{post} = O_{pre} \\times LR$$\n\nFirst, we address the initial condition and the first test (positive ELISA).\nThe given pre-test probability of HIT is $P_{pre} = 0.15$. We convert this to a fraction: $P_{pre} = \\frac{15}{100} = \\frac{3}{20}$.\nWe calculate the pre-test odds, $O_{pre}$:\n$$O_{pre} = \\frac{P_{pre}}{1 - P_{pre}} = \\frac{\\frac{3}{20}}{1 - \\frac{3}{20}} = \\frac{\\frac{3}{20}}{\\frac{17}{20}} = \\frac{3}{17}$$\nThe first test is a positive Enzyme-Linked Immunosorbent Assay (ELISA), for which the positive likelihood ratio is given as $LR^{+}_{ELISA} = 2$. We use this to calculate the post-test odds after the ELISA, denoted as $O_{post,1}$:\n$$O_{post,1} = O_{pre} \\times LR^{+}_{ELISA} = \\frac{3}{17} \\times 2 = \\frac{6}{17}$$\nNext, we convert these post-test odds back into a post-test probability, $P_{post,1}$:\n$$P_{post,1} = \\frac{O_{post,1}}{1 + O_{post,1}} = \\frac{\\frac{6}{17}}{1 + \\frac{6}{17}} = \\frac{\\frac{6}{17}}{\\frac{17+6}{17}} = \\frac{\\frac{6}{17}}{\\frac{23}{17}} = \\frac{6}{23}$$\nThis is the post-test probability of HIT after a positive ELISA result. This fraction is in its simplest form as $23$ is a prime number.\n\nSecond, we incorporate the result of the subsequent test (negative SRA). The probability $P_{post,1}$ (or odds $O_{post,1}$) now serves as the pre-test probability (or odds) for the second stage of testing. The problem states the assumption of conditional independence of test results given the disease status, which validates this sequential update.\nThe pre-test odds for the second test are $O_{pre,2} = O_{post,1} = \\frac{6}{17}$.\nThe second test is a negative Serotonin Release Assay (SRA), with a given negative likelihood ratio of $LR^{-}_{SRA} = 0.05$. We express this as a fraction: $LR^{-}_{SRA} = \\frac{5}{100} = \\frac{1}{20}$.\nWe calculate the final post-test odds, $O_{post,2}$, after the negative SRA:\n$$O_{post,2} = O_{pre,2} \\times LR^{-}_{SRA} = \\frac{6}{17} \\times \\frac{1}{20} = \\frac{6}{340} = \\frac{3}{170}$$\nFinally, we convert these final odds back into the final post-test probability, $P_{post,2}$:\n$$P_{post,2} = \\frac{O_{post,2}}{1 + O_{post,2}} = \\frac{\\frac{3}{170}}{1 + \\frac{3}{170}} = \\frac{\\frac{3}{170}}{\\frac{170+3}{170}} = \\frac{\\frac{3}{170}}{\\frac{173}{170}} = \\frac{3}{173}$$\nThis is the final post-test probability of HIT after the positive ELISA and subsequent negative SRA. This fraction is in its simplest form as $173$ is a prime number.\n\nThe two requested probabilities, in order, are the probability after the positive ELISA and the probability after the subsequent negative SRA.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n\\frac{6}{23}  \\frac{3}{173}\n\\end{pmatrix}\n}\n$$", "id": "4845848"}, {"introduction": "Real-world clinical practice rarely presents with textbook clarity, especially in the intensive care unit where patients often have multiple reasons for thrombocytopenia. This final exercise presents a complex case that challenges you to integrate your skills: you must apply the 4Ts score amidst numerous confounders, recognize the specific pattern of rapid-onset HIT [@problem_id:4845872], and determine the correct, urgent management steps. This problem simulates the high-stakes decision-making required in the management of critically ill patients.", "problem": "A $72$-year-old man is admitted to the Intensive Care Unit (ICU) with septic shock due to cholangitis. On hospital day $0$ at $18{:}00$, he is started on unfractionated heparin (UFH) $5{,}000$ units subcutaneously every $8$ hours for venous thromboembolism prophylaxis. Twelve days prior to this admission, he was hospitalized for a non–ST-elevation myocardial infarction and received an intravenous UFH infusion for approximately $48$ hours. His platelet count on admission (day $0$ at $12{:}00$) is $235{,}000/\\mu\\mathrm{L}$. By day $1$ at $08{:}00$, his platelet count is $118{,}000/\\mu\\mathrm{L}$, and by day $2$ at $08{:}00$, it is $92{,}000/\\mu\\mathrm{L}$. On day $2$, his right upper extremity becomes swollen; duplex ultrasonography demonstrates an acute, occlusive thrombosis of the right brachial vein surrounding a peripherally inserted central catheter. Peripheral blood smear shows no schistocytes. Fibrinogen is $520$ mg/dL, international normalized ratio is $1.1$, activated partial thromboplastin time is $30$ s, and D-dimer is elevated. He received $2$ units of packed red blood cells on day $0$ for hemoglobin $6.9$ g/dL. Continuous renal replacement therapy with regional citrate anticoagulation was initiated on day $1$. Linezolid was started on day $1$ for suspected methicillin-resistant Staphylococcus aureus coverage. He is hemodynamically improving and has no active bleeding.\n\nHeparin-induced thrombocytopenia (HIT) is considered among several possible etiologies of thrombocytopenia in this ICU patient. Using the 4Ts score (Thrombocytopenia, Timing, Thrombosis, and oTher causes), determine his pretest probability category and choose the single best next step that prioritizes the HIT workup appropriately versus other etiologies.\n\nWhich of the following is the best next step?\n\nA. Assign a low 4Ts score (total $2$–$3$); do not test for HIT; continue all heparin while pursuing sepsis-associated disseminated intravascular coagulation as the cause\n\nB. Assign an intermediate 4Ts score (total $4$–$5$); send platelet factor $4$ (PF4)–heparin enzyme-linked immunosorbent assay (ELISA), stop all heparin, and start a non-heparin anticoagulant at therapeutic dose pending results\n\nC. Assign a high 4Ts score (total $6$–$8$); send PF4–heparin ELISA and a functional assay such as the serotonin release assay (SRA), immediately stop all heparin, and initiate therapeutic-dose non-heparin anticoagulation; avoid platelet transfusions unless bleeding\n\nD. Attribute thrombocytopenia to sepsis and catheter-related consumption; give platelet transfusions to maintain platelet count $100{,}000/\\mu\\mathrm{L}$ and continue heparin while awaiting additional data\n\nE. Assign an intermediate 4Ts score; send PF4–heparin ELISA but continue heparin until confirmatory testing returns, because thrombosis is catheter-related", "solution": "The user wants me to critically evaluate a clinical problem concerning heparin-induced thrombocytopenia (HIT) and determine the best next step in management.\n\n### Step 1: Extract Givens\n\n- **Patient:** A $72$-year-old man in the Intensive Care Unit (ICU).\n- **Diagnosis:** Septic shock due to cholangitis.\n- **Current Heparin Exposure:** Started on hospital day $0$ at $18{:}00$, receiving unfractionated heparin (UFH) $5{,}000$ units subcutaneously every $8$ hours.\n- **Prior Heparin Exposure:** Received an intravenous UFH infusion for approximately $48$ hours, $12$ days prior to the current admission.\n- **Platelet Counts:**\n    - Day $0$ at $12{:}00$ (admission baseline): $235{,}000/\\mu\\mathrm{L}$.\n    - Day $1$ at $08{:}00$: $118{,}000/\\mu\\mathrm{L}$.\n    - Day $2$ at $08{:}00$ (nadir): $92{,}000/\\mu\\mathrm{L}$.\n- **Thrombotic Event:** On day $2$, an acute, occlusive thrombosis of the right brachial vein was demonstrated by duplex ultrasonography.\n- **Other Laboratory Data on Day 2:**\n    - Peripheral blood smear: No schistocytes.\n    - Fibrinogen: $520$ mg/dL (high).\n    - International Normalized Ratio (INR): $1.1$ (normal).\n    - Activated Partial Thromboplastin Time (aPTT): $30$ s (normal).\n    - D-dimer: Elevated.\n- **Other Clinical Information:**\n    - Received $2$ units of packed red blood cells on day $0$.\n    - Continuous renal replacement therapy (CRRT) with regional citrate anticoagulation was initiated on day $1$.\n    - Linezolid was started on day $1$.\n    - Hemodynamically improving, no active bleeding.\n- **Task:** Use the 4Ts score to determine the pretest probability of HIT and select the best next step.\n\n### Step 2: Validate Using Extracted Givens\n\n- **Scientifically Grounded:** The problem describes a realistic and complex clinical scenario involving a critically ill patient. The differential diagnosis of thrombocytopenia in the ICU, the use of the 4Ts score, and the principles of HIT management are all based on established medical science and clinical guidelines. The presentation is classic for a potential case of rapid-onset HIT.\n- **Well-Posed:** The problem provides sufficient, consistent data to calculate the 4Ts score and evaluate the clinical situation. A unique score can be derived, leading to a specific pretest probability category and a standard-of-care management plan.\n- **Objective:** The language is clinical and objective. The provided data points are quantitative and factual.\n\nThe problem statement is valid. It is a well-formed clinical vignette that requires the application of a standard diagnostic algorithm (the 4Ts score) to guide management.\n\n### Step 3: Problem Solution and Option Analysis\n\nThe core of the task is to calculate the 4Ts score for this patient to stratify the risk of HIT. The score consists of four components, each scored from $0$ to $2$.\n\n1.  **Thrombocytopenia (the first 'T'):**\n    - The baseline platelet count is $235{,}000/\\mu\\mathrm{L}$. The nadir is $92{,}000/\\mu\\mathrm{L}$.\n    - The percentage drop in platelet count is $\\frac{235{,}000 - 92{,}000}{235{,}000} \\times 100\\% \\approx 60.9\\%$.\n    - A platelet count fall $50\\%$ scores $2$ points. The platelet nadir of $92{,}000/\\mu\\mathrm{L}$ is within the $20{,}000 - 100{,}000/\\mu\\mathrm{L}$ range, which also qualifies for $2$ points.\n    - **Score for Thrombocytopenia = $2$ points.**\n\n2.  **Timing of platelet fall (the second 'T'):**\n    - The patient had a prior heparin exposure within the last $100$ days (specifically, $12$ days prior to this admission).\n    - The platelet count began to fall within one day of restarting heparin (from day $0$ to day $1$).\n    - A platelet count fall occurring $\\le 1$ day after heparin re-initiation in a patient with a prior heparin exposure within the last $30$ days is characteristic of rapid-onset HIT. This meets the criteria for the highest score.\n    - **Score for Timing = $2$ points.**\n\n3.  **Thrombosis or other sequelae (the third 'T'):**\n    - The patient has a newly diagnosed, objectively confirmed acute occlusive thrombosis of the right brachial vein.\n    - The presence of a new, confirmed thrombosis scores the maximum points.\n    - **Score for Thrombosis = $2$ points.**\n\n4.  **oTher causes of thrombocytopenia (the fourth 'T'):**\n    - We must consider alternative causes for the patient's low platelet count. The patient has septic shock, is in the ICU, has a central line, is on CRRT, and was started on linezolid.\n    - Sepsis is a very common cause of thrombocytopenia. This constitutes a *possible* alternative cause.\n    - However, overt disseminated intravascular coagulation (DIC) is less likely given the normal INR ($1.1$) and high fibrinogen ($520$ mg/dL, which is an acute phase reactant and would be consumed/low in DIC). Linezolid-induced thrombocytopenia typically has a later onset.\n    - According to the 4Ts scoring system, if an alternative cause is *possible*, this component is scored as $1$ point. If no other cause is apparent, it is $2$ points. If a definite alternative cause is present, it is $0$ points. Given the strong possibility of sepsis contributing, but the clinical picture being highly suspicious for HIT, a score of $1$ is most appropriate.\n    - **Score for oTher causes = $1$ point.**\n\n**Total 4Ts Score Calculation:**\nTotal Score = (Thrombocytopenia) + (Timing) + (Thrombosis) + (oTher causes)\nTotal Score = $2 + 2 + 2 + 1 = 7$ points.\n\n**Interpretation:**\n- A score of $0-3$ points = Low pretest probability.\n- A score of $4-5$ points = Intermediate pretest probability.\n- A score of $6-8$ points = High pretest probability.\nWith a score of $7$, this patient has a **high pretest probability** for HIT.\n\n**Management for High Pretest Probability HIT:**\n- Immediately discontinue all sources of heparin (including prophylactic UFH, flushes, and heparin-coated catheters).\n- Initiate a non-heparin anticoagulant at a therapeutic dose (not prophylactic), especially since thrombosis is already present. Suitable agents in the ICU setting include argatroban or bivalirudin.\n- Send laboratory tests to confirm the diagnosis. For high-probability cases, this includes sending a HIT immunoassay (e.g., PF4-heparin ELISA) and strongly considering sending a confirmatory functional assay (e.g., serotonin release assay [SRA] or heparin-induced platelet aggregation [HIPA] assay) concurrently or as a follow-up to a positive immunoassay.\n- Avoid platelet transfusions, as they may paradoxically increase the thrombotic risk in HIT, unless the patient has life-threatening bleeding.\n\n### Option-by-Option Analysis\n\n**A. Assign a low 4Ts score (total $2$–$3$); do not test for HIT; continue all heparin while pursuing sepsis-associated disseminated intravascular coagulation as the cause**\n- The assigned score is incorrect; the calculated score is $7$ (high probability).\n- The recommended actions (continue heparin, do not test) are dangerous and contrary to all clinical guidelines for managing a patient with high suspicion for HIT.\n- **Verdict: Incorrect.**\n\n**B. Assign an intermediate 4Ts score (total $4$–$5$); send platelet factor $4$ (PF4)–heparin enzyme-linked immunosorbent assay (ELISA), stop all heparin, and start a non-heparin anticoagulant at therapeutic dose pending results**\n- The assigned score is incorrect; the calculated score is $7$ (high probability), not intermediate. Although the management steps are mostly correct for an intermediate or high probability case, the initial risk stratification is flawed.\n- **Verdict: Incorrect.**\n\n**C. Assign a high 4Ts score (total $6$–$8$); send PF4–heparin ELISA and a functional assay such as the serotonin release assay (SRA), immediately stop all heparin, and initiate therapeutic-dose non-heparin anticoagulation; avoid platelet transfusions unless bleeding**\n- The assigned score category is correct (a score of $7$ is in the $6-8$ range).\n- The recommended management plan is entirely correct and follows standard-of-care guidelines for high-probability HIT with thrombosis (HITT): stop heparin, start a therapeutic-dose alternative anticoagulant, send appropriate serological tests, and avoid platelet transfusions. Suggesting both ELISA and a functional assay reflects the high degree of suspicion.\n- **Verdict: Correct.**\n\n**D. Attribute thrombocytopenia to sepsis and catheter-related consumption; give platelet transfusions to maintain platelet count $100{,}000/\\mu\\mathrm{L}$ and continue heparin while awaiting additional data**\n- This option incorrectly dismisses HIT despite the high pretest probability.\n- Continuing heparin is contraindicated.\n- Administering platelet transfusions in the absence of major bleeding is contraindicated in HIT and can worsen thrombosis. The target of $100{,}000/\\mu\\mathrm{L}$ is arbitrary and not indicated.\n- **Verdict: Incorrect.**\n\n**E. Assign an intermediate 4Ts score; send PF4–heparin ELISA but continue heparin until confirmatory testing returns, because thrombosis is catheter-related**\n- The assigned score category is incorrect.\n- The recommendation to continue heparin pending test results is a critical error and places the patient at high risk for further thrombosis. The fact that a thrombosis is catheter-related does not exclude HIT; in fact, it is a common presentation.\n- **Verdict: Incorrect.**", "answer": "$$\\boxed{C}$$", "id": "4845872"}]}